Intellia CEO John M. Leonard disposes of USD 286,764 in common shares
NTLA•CEO share sales reported
Intellia Therapeutics President and CEO John M. Leonard sold 22,675 common shares on Aug. 20-21.
- Sales were priced at USD 12.6 per share on Aug. 20 and USD 13 per share on Aug. 21.
- His directly held stake fell to 1,147,064 shares following the transactions.
- A separate trust holding was reported at 58,415 shares.




